{"url":"https://lda.senate.gov/api/v1/filings/687b0730-e00d-4ded-981f-8afaad2de48d/","filing_uuid":"687b0730-e00d-4ded-981f-8afaad2de48d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2020,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/687b0730-e00d-4ded-981f-8afaad2de48d/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Marina Castillo","dt_posted":"2020-04-20T16:51:56.563000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street NW, 6th Floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":65191,"url":"https://lda.senate.gov/api/v1/registrants/65191/","house_registrant_id":35579,"name":"VENN STRATEGIES","description":"A political and public affairs consulting firm.","address_1":"750 9th St NW, Suite 650","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAY ENGLESON","contact_telephone":"+1 301-509-9933","dt_updated":"2026-07-20T11:43:32.403140-04:00"},"client":{"id":204572,"url":"https://lda.senate.gov/api/v1/clients/204572/","client_id":1003771,"name":"CIVICA INC.","general_description":"Health care systems & supplier of generic drugs at a fair price to prevent shortages.","client_government_entity":false,"client_self_select":null,"state":"UT","state_display":"Utah","country":"US","country_display":"United States of America","ppb_state":"UT","ppb_state_display":"Utah","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-03-17"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Matters relating to health care systems & suppliers of generic drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70081,"prefix":null,"prefix_display":null,"first_name":"EMILIA","nickname":null,"middle_name":null,"last_name":"DISANTO","suffix":null,"suffix_display":null},"covered_position":"Deputy Inspector General, US Department of State; Chief of Staff, Federal Housing Finance Agency Office of Inspector General; Chief Investigative Counsel & Special Counsel, US Senate Committee on Finance","new":false},{"lobbyist":{"id":71622,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FAWLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}